eLetters is an online forum for ongoing peer review. To submit an eLetter please go to the article you wish to respond to and click on the link that reads "eLetters: Submit a Response." Submission of eLetters are open to all health care professionals and experts in related fields.

eLetters to:

ELECTRONIC ARTICLE:
David Michelson, Douglas Faries, Joachim Wernicke, Douglas Kelsey, Katherine Kendrick, F. Randy Sallee, Thomas Spencer, and the Atomoxetine ADHD Study Group
Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study
Pediatrics 2001; 108: e83 [Abstract] [Full text] [PDF]
*eLetters: Submit a response to this article

eLetters published:

[Read eLetters] What about adults?
Stephen Shunk   (14 November 2001)
[Read eLetters] Response to What about adults?
David Michelson   (14 November 2001)

What about adults? 14 November 2001
Next eLetters Top
Stephen Shunk,
PR Consultant
Community Solutions

Send letter to journal:
Re: What about adults?

3sisters{at}outlawnet.com Stephen Shunk

What, if any, efforts have yet been made to test this new drug on adults with ADHD? If so, what are the results? If not, what projections, if any, have been made as to its application for adults?

Thank you.

Response to What about adults? 14 November 2001
Previous eLetters Top
David Michelson,
physician
Lilly Research Laboratories

Send letter to journal:
Re: Response to What about adults?

dmichelson{at}lilly.com David Michelson

Atomoxetine has been studied in adults. One study showing superiority of atomoxetine to placebo has been published (Spencer T. et al. Am J Psychiatry 1998). Two further studies have been conducted, and once analyses of the data are completed and prepared for publication, we will report results.

David Michelson